https://www.selleckchem.com/pr....oducts/cilofexor-gs-
19 to -0.02]; p = 0.02) when compared to patients treated for 1-2 or 5days. Also, timing of the pooled mortality assessment indicated a reduction concerning short-term mortality ( 30days; risk difference, -0.08 [95% CI -0.15 to -0.01]; p = 0.02; p for Cochran Q = 0.02; I = 63%). Presence of statistical heterogeneity was noted with no sign of significant publication bias. Although vitamin C administration did not reduce pooled mortality, patients may profit if vitamin C is administered over 3 to 4days. Consequently, f
Like
Comment
Share
